Brian Levy - Chief Executive Officer @ Inflammx Therapeutics - Crunchbase Person Profile

Start Free Trial

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Primary Job Title Chief Executive Officer
Primary Organization
Inflammx Therapeutics

Location New York, New York, United States
Regions Greater New York Area, East Coast, Northeastern US
Gender Male

Investor Type
obfuscated
obfuscation
Investor Stage
obfuscated
obfuscation

LinkedIn View on LinkedIn

Brian Levy is the Chief Executive Officer at InflammX Therapeutics. Brian attended University of California, Berkeley.

Personal Investments

Number of Investments

has made

investments. Their latest investment was

Seed Round - Willow

on

obfuscation

, when

raised

obfuscation

.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Willow	—	Seed Round - Willow	obfuscated obfuscation
obfuscated obfuscation	HUBBLE	No	Series A - HUBBLE	obfuscated obfuscation
obfuscated obfuscation	HUBBLE	—	Seed Round - HUBBLE	obfuscated obfuscation
obfuscated obfuscation	HUBBLE	—	Seed Round - HUBBLE	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

has

current jobs including

Chief Executive Officer

at

Inflammx Therapeutics

,

CEO

at

Ocunexus Therapeutics

, and

Chief Executive Officer, President

at

Inflammx Therapeutics

. Additionally,

has had

past jobs including

Chief Executive Officer

at

Ocunexus Therapeutics

.

Inflammx Therapeutics Chief Executive OfficerJan 2020
Ocunexus Therapeutics CEO
Inflammx Therapeutics Chief Executive Officer, President
Silk Technologies Chairman

Organization Name	Title At Company	Start Date	End Date
Ocunexus Therapeutics	Chief Executive Officer	Oct 2016	Jun 2022
Aerie Pharmaceuticals	Chief Medical Officer	Jan 2012	Jul 2015
Nexis Vision	Chief Scientific and Operating Officer	Jun 2010	Sep 2011
Danube	Chief Operating Officer	Jun 2008	Jun 2009
Bausch & Lomb	Chief Medical Officer	Feb 2004	Jun 2008
Bausch & Lomb	Vice President R&D, Clinical Development and Medical Affairs	Sep 1994	Feb 2004
California Pacific Medical Center	Associate Professor and Director Medical Contact Lens Service	1989	Sep 1, 1994
California Pacific Medical Center	Associate Clinical Professor Ophthalmology	1989	1994
University of Rochester Medical Center	Clinical Professor Dept of Ophthalmology	2005	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

holds

board and advisor roles as

Board of Directors Member

at

Ocata Therapeutics

and

Director

at

.

Ocata Therapeutics Board of Directors MemberAug 29, 2015
HUBBLE Director

Related Hubs

Hub Name	CB Rank (Hub)
Therapeutics Early Stage Companies With Fewer Than 50 Employees	55,838
Therapeutics Companies with Early Stage Venture Funding	50,018
Therapeutics Early Stage Companies With More Than 10 Employees	59,772
Therapeutics Early Stage Companies With Less Than $500M in Revenue	64,891
United States Therapeutics Companies with Early Stage Venture Funding	57,817
East Coast Health Care Companies with Early Stage Venture Funding	67,266
Therapeutics Early Stage Companies With Less Than $50M in Revenue	68,661
Therapeutics Early Stage Companies With Less Than $10M in Revenue	72,325
East Coast Startups Founded in 2020	30,433
Therapeutics Early Stage Companies With More Than $1M in Revenue	66,831

Education

studied at

University of California Berkeley

,

University of Waterloo

, and

Columbia Business School

.

University of California Berkeley ODunknown1976
University of Waterloo MSComparative Anatomy & Physiology of the Eye1979
Columbia Business School unknownExecutive Development

Events

Number of Events

has participated in

event,

Ocular Diseases Drug Discovery

on

Mar 20, 2017

.

Ocular Diseases Drug Discovery Speaker San Diego, California, United States, North AmericaMar 20, 2017

Recent News and Activity

Number of News Articles

Funding Round•

Jul 31, 2018

Willow raised

obfuscation

from Brian Levy and 5 other investors

Discover more funding rounds

News•

Nov 8, 2017

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Funding Round•

Mar 7, 2017

HUBBLE raised

obfuscation

from Brian Levy and 5 other investors

Discover more funding rounds

News•

Nov 2, 2016

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Nov 2, 2016

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Nov 1, 2016

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Nov 1, 2016

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Funding Round•

Oct 15, 2016

HUBBLE raised

obfuscation

from Brian Levy and 5 other investors

Discover more funding rounds

News•

Aug 12, 2016

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Jun 13, 2016

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated